ParkinsonFranceV1, USA, Analysis, indexHead, KwdEn.i

Index : Keywords

Liste des classifications (clusters par fréquence et par distance de cosinus):

Les termes de plus forte occurence

201	Parkinson disease
137	Humans
111	Nervous system diseases
85	Male
78	Human
67	Female
64	Aged
59	Middle Aged
58	Parkinson's disease
49	Animals
37	Treatment
34	Parkinson Disease (genetics)
34	Adult
29	Parkinson Disease (physiopathology)
28	Aged, 80 and over
25	Parkinson Disease (complications)
23	Animal
22	Parkinson Disease (drug therapy)
21	Dopamine
20	Parkinson Disease (metabolism)
20	Mice
19	Parkinson Disease (pathology)
18	Disease Models, Animal
17	Subthalamic nucleus
16	Parkinson Disease (therapy)
16	Levodopa
15	Mutation
15	Diagnosis
15	Deep brain stimulation
15	Basal ganglion
14	Parkinson Disease (diagnosis)
14	Dyskinesia
13	Risk factor
13	Rat
13	Locus niger
13	Comparative study
12	rating scales
12	Genetics
12	Dopamine (metabolism)
12	Corpus striatum
12	Antiparkinson Agents (therapeutic use)
11	deep brain stimulation
11	Neurons (metabolism)
11	France
11	Dementia
11	Antiparkinson agent
11	Animal model
11	Alzheimer disease
10	Risk Factors
10	Review
10	Recommendation
10	Pathogenesis
10	Parkinson Disease (epidemiology)
10	Mice, Inbred C57BL
10	Depression
10	Degeneration
10	Case-Control Studies
10	Brain (metabolism)
9	clinimetrics
9	Rats
9	Prognosis
9	Parkinson Disease (psychology)
9	Mouse
9	Motor control
9	Levodopa (therapeutic use)
9	Europe
9	Epidemiology
9	Dopamine agonist
8	Substantia Nigra (metabolism)
8	Severity of Illness Index
8	Neuropsychological Tests
8	Neurons (pathology)
8	Mice, Knockout
8	Genotype
8	Force
8	Double-Blind Method
8	Corpus Striatum (metabolism)
7	substantia nigra
7	levodopa
7	alpha-Synuclein (metabolism)
7	alpha-Synuclein (genetics)
7	Validity
7	Pedigree
7	Parkinson Disease (etiology)
7	Monkey
7	Medicine
7	Mechanism of action
7	Immunohistochemistry
7	History, 19th Century
7	Gene
7	Evaluation scale
7	Electrophysiology
7	Dose-Response Relationship, Drug
7	Complication
7	Chemotherapy
7	Central nervous system
7	Brain (pathology)
6	subthalamic nucleus
6	reliability
6	depression
6	Young Adult
6	Tremor
6	Treatment Outcome
6	Time Factors
6	Surgery
6	Substantia Nigra (pathology)
6	Reliability
6	Pramipexole
6	Parkinsonism
6	Parkinson Disease (history)
6	Nerve Degeneration (pathology)
6	Multiple system atrophy
6	Models
6	Mice, Transgenic
6	MPTP
6	Genetic determinism
6	Genetic Predisposition to Disease
6	Evolution
6	Dystonia
6	Dopaminergic neuron
6	Dopaminergic Neurons (metabolism)
6	Case control study
6	Brain (vertebrata)
6	Apoptosis
6	Analysis of Variance
6	Agonist
6	Adolescent
5	validity
5	tau Proteins (genetics)
5	psychometrics
5	neuroprotection
5	dyskinesia
5	dementia
5	Validation
5	Supranuclear ophthalmoplegia
5	Subthalamic Nucleus (physiopathology)
5	Substantia Nigra (drug effects)
5	Safety
5	Psychomotor Performance (physiology)
5	Psychometrics
5	Polymorphism, Single Nucleotide
5	Placebo
5	Phenotype
5	Neuron
5	Neurology
5	Mutation (genetics)
5	Lewy body
5	Instrumental stimulation
5	History, 20th Century
5	High frequency
5	Family study
5	Exploration
5	Enzyme inhibitor
5	Emission tomography
5	Elderly
5	Early
5	Differential diagnostic
5	Deep Brain Stimulation (methods)
5	Cognitive disorder
5	Clinical trial
5	Clinical management
5	Brain (physiopathology)
5	Antiparkinson Agents (adverse effects)
5	Age of Onset
5	Age Factors
5	Advanced stage
4	treatment
4	dopamine agonists
4	basal ganglia
4	United States
4	Toxicology
4	Surveys and Questionnaires
4	Substantia Nigra (cytology)
4	Ropinirole
4	Risk
4	Reproducibility of Results
4	Release
4	Rats, Sprague-Dawley
4	Putamen
4	Protein Kinases (metabolism)
4	Progressive
4	Pathology
4	Parkinson Disease (mortality)
4	Oxidative stress
4	Movement (physiology)
4	Motor system disorder
4	Levodopa (adverse effects)
4	Huntington disease
4	Genetic linkage
4	Genetic Linkage
4	Genetic Association Studies
4	Gait
4	Familial disease
4	Encephalon
4	Electric Stimulation Therapy
4	Double blind study
4	Dopaminergic Neurons (pathology)
4	Disease Progression
4	Depression (psychology)
4	Degenerative disease
4	Deep Brain Stimulation
4	D2 Dopamine receptor
4	Cross-Sectional Studies
4	Chronic
4	Cell death
4	Cartography
4	Body movement
4	Biological activity
4	Basal Ganglia (physiopathology)
4	Anxiety
4	Accuracy
3	striatum
3	rat
3	neurotoxicity
3	neurosurgery
3	neurodegeneration
3	multiple system atrophy
3	motor fluctuations
3	motor complications
3	globus pallidus
3	evidence‐based medicine
3	dopamine transporter
3	dopamine agonist
3	diagnostic criteria
3	development
3	apoptosis
3	anxiety
3	antitumor agents
3	Tyrosine 3-Monooxygenase (metabolism)
3	Transplantation
3	Toxicity
3	Tobacco smoking
3	Timing
3	Thalamus
3	Symptomatology
3	Survival Rate
3	Subthalamic Nucleus (physiology)
3	Striated muscle
3	Speech
3	Signal Transduction
3	Sign
3	Sex Distribution
3	Reaction time
3	Reaction Time (physiology)
3	Rasagiline
3	Radiodiagnosis
3	RNA, Messenger (metabolism)
3	Quality of Life
3	Public health
3	Psychiatric Status Rating Scales
3	Protein-Serine-Threonine Kinases (genetics)
3	Primates
3	Prevalence
3	Postural Balance
3	Positron
3	Point Mutation
3	Piperidines (therapeutic use)
3	Phosphorylation
3	Pesticides
3	Pathophysiology
3	Parkinson’s disease
3	Parkinsonian Disorders (pathology)
3	Parkinson
3	Parkinson Disease, Secondary (chemically induced)
3	Parkinson Disease (surgery)
3	Parkin
3	Pallidum
3	Oxidopamine
3	Oral administration
3	Nigrostriatal pathway
3	Nicotinic receptor
3	Neurotoxin
3	Neuroprotective Agents (therapeutic use)
3	Neurons (enzymology)
3	Neurons (drug effects)
3	Neurons (cytology)
3	Neurofibrillary tangle
3	Neural Pathways (metabolism)
3	Nerve Tissue Proteins (genetics)
3	Mortality
3	Molecular Sequence Data
3	Mitochondria (metabolism)
3	Lewy body dementia
3	Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
3	Learning
3	Indans (therapeutic use)
3	Incidence
3	Glutamate
3	Genetic mapping
3	Genetic Predisposition to Disease (genetics)
3	Gene Expression Regulation (genetics)
3	Follow-Up Studies
3	Experimental disease
3	Evaluation
3	Europe (epidemiology)
3	Etiology
3	Epilepsy
3	Electrodes, Implanted
3	Dyskinesia, Drug-Induced (metabolism)
3	Dysfunction
3	Dopaminergic Neurons (drug effects)
3	Dopamine Agents (therapeutic use)
3	Depression (diagnosis)
3	DNA Mutational Analysis
3	D1 Dopamine receptor
3	Critical study
3	Corpus Striatum (physiopathology)
3	Cohort study
3	Cells, Cultured
3	Cell Death (physiology)
3	Brain (cytology)
3	Blotting, Western
3	Basal Ganglia (physiology)
3	Association
3	Apathy
3	Antiparkinson Agents (administration & dosage)
3	Antagonist
3	Amino Acid Substitution
3	Amine oxidase (flavin-containing)
3	Amantadine
3	Alleles
3	Activities of Daily Living (psychology)
3	AMPA receptor
2	α‐synuclein
2	α synuclein
2	wehrlite
2	tyrosine hydroxylase
2	transcranial magnetic stimulation
2	tau Proteins (analysis)
2	stereotaxis
2	sarizotan
2	reaction time
2	reaching
2	randomized clinical trials
2	pulsars: general
2	primate
2	pramipexole
2	planetary systems
2	photodynamic therapy
2	perampanel
2	partial dopamine agonist
2	myelin
2	mutation
2	multiple sclerosis
2	mouse
2	monotherapy
2	monoamine oxidase inhibitors
2	methods: statistical
2	meta‐analysis
2	metabolism
2	immunocytochemistry
2	human
2	executive functions
2	dystonia
2	dyskinesias
2	diagnosis
2	developmental toxicology terminology
2	developmental toxicology nomenclature
2	developmental toxicology glossary
2	cognition
2	calbindin
2	apathy
2	anticholinergics
2	amantadine
2	alpha-Synuclein (chemistry)
2	accuracy
2	Vision
2	Ventral tegmental area
2	Ubiquitin-Protein Ligases (metabolism)
2	Ubiquitin-Protein Ligases (genetics)
2	Ubiquitin Thiolesterase
2	Tookad
2	Tomography, Emission-Computed, Single-Photon
2	Thiolester Hydrolases (genetics)
2	Tetrahydronaphthalenes (adverse effects)
2	Terminology as Topic
2	Technique
2	Tau protein
2	Synuclein
2	Syndrome
2	Supranuclear Palsy, Progressive (drug therapy)
2	Supranuclear Palsy, Progressive (diagnosis)
2	Subthalamic Nucleus (surgery)
2	Subthalamic Nucleus (pathology)
2	Substantia Nigra (enzymology)
2	Stereoisomerism
2	Statistics, Nonparametric
2	Societies, Scientific (standards)
2	Smoking (adverse effects)
2	Sleep disorder
2	Signal Transduction (physiology)
2	Signal Transduction (genetics)
2	Signal Transduction (drug effects)
2	Sialorrhea
2	Sex Factors
2	Serotonin (metabolism)
2	Sequence Homology, Amino Acid
2	Senescence
2	Sarizotan
2	S100 Calcium Binding Protein G (metabolism)
2	Rivastigmine
2	Revision
2	Reference Values
2	Reference Standards
2	Receptors, Dopamine D1 (metabolism)
2	Rapid eye movement sleep
2	Randomized Controlled Trials as Topic
2	Quality of life
2	Pyridines (therapeutic use)
2	Pyridines (adverse effects)
2	Pyridines (administration & dosage)
2	Pyrenes (chemistry)
2	Psychotropic
2	Psychomotor Performance (drug effects)
2	Protein Kinases (genetics)
2	Proprioception
2	Projection
2	Programming
2	Prodrugs (adverse effects)
2	Prodromal Symptoms
2	Predictive factor
2	Predictive Value of Tests
2	Posture
2	Postural hypotension
2	Positron emission tomography
2	Population
2	Polymorphism, Single Nucleotide (genetics)
2	Polymerase chain reaction
2	Polymerase Chain Reaction
2	Planning
2	Pharmacology
2	Pesticides (adverse effects)
2	Perampanel
2	Partial agonist
2	Parkinsonian Disorders (metabolism)
2	Parkinsonian Disorders (genetics)
2	Parkinsonian Disorders (drug therapy)
2	Parkinson Disease, Secondary (metabolism)
2	Parkinson Disease, Secondary (drug therapy)
2	Parkinson Disease (rehabilitation)
2	Parkinson Disease (enzymology)
2	Paris
2	Pardoprunox
2	Papio anubis
2	Oxidopamine (toxicity)
2	Oxidative Stress
2	Odds Ratio
2	Nucleotide sequence
2	Neuroprotective Agents (pharmacology)
2	Neurons (ultrastructure)
2	Neurons (chemistry)
2	Neuromodulation
2	Neurology (history)
2	Neurofibrillary Tangles (chemistry)
2	Neurodegenerative Diseases (genetics)
2	Neural Pathways
2	Neural Pathways (physiopathology)
2	Nervous system
2	Nerve Net (physiopathology)
2	Nerve Degeneration (metabolism)
2	Nerve Degeneration (genetics)
2	Nerve Degeneration (etiology)
2	NF1
2	Myelodysplastic syndrome
2	Muscle contraction
2	Multicenter Studies as Topic
2	Motor Activity (drug effects)
2	Morphology
2	Molecular model
2	Modulation
2	Modification
2	Models, Statistical
2	Models, Molecular
2	Modeling
2	Mitochondrial Degradation (genetics)
2	Mitochondria
2	Mitochondria (drug effects)
2	Midbrain
2	Microsatellite Repeats (genetics)
2	Microglia
2	Metabolite
2	Memory
2	Membrane Glycoproteins (genetics)
2	Medical screening
2	Medical Records
2	Mass spectrometry
2	Markov Chains
2	Malignant tumor
2	Magnetic Resonance Imaging
2	Macaca fascicularis
2	MPTP Poisoning
2	MPTP Poisoning (physiopathology)
2	MPP+
2	Long term
2	Logistic Models
2	Lod Score
2	Locus
2	Locomotion
2	Localization
2	Lipids

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/corpus/ParkinsonFrance.storage/ParkinsonFranceV1/Data/USA/Analysis/KwdEn.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration) - Analysis (USA) Index « Mots-clés originaux en anglais » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration) - Analysis (USA)Index « Mots-clés originaux en anglais » - tête de navigation

Index : Keywords

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

La maladie de Parkinson en France (serveur d'exploration) - Analysis (USA)

Index « Mots-clés originaux en anglais » - tête de navigation